AngioDynamics to Report Fiscal 2012 Fourth Quarter and Full Year Financial Results and Hold Conference Call on July 12, 2012

July 3, 2012 at 11:45 AM EDT

ALBANY, N.Y., July 3, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that it will report its fiscal 2012 fourth quarter and full year financial results on Thursday, July 12, 2012, after the close of the U.S. financial markets.

Management will host an investment community conference call beginning at 4:30 p.m. Eastern Time on July 12, 2012, to discuss the results and to answer questions.

To participate in the live call by telephone, please dial +1 (800) 762-8779.

Those interested in listening to the conference call live via the Internet may do so by visiting the Investor Relations section of AngioDynamics' Web site at http://investors.angiodynamics.com. To listen to the live call, please go to the Web site 15 minutes prior to its start to register, download and install the necessary audio software. The conference call will also be archived on the Web site.

About AngioDynamics

AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products and venous products. More information is available at www.AngioDynamics.com.

CONTACT: Company Contact:

         AngioDynamics, Inc.D. Joseph Gersuk, CFO

         (800) 772-6446 x1608

         jgersuk@AngioDynamics.com



         Investor Relations Contacts:

         EVC Group, Inc.Robert Jones/ Jamar Ismail

         (646) 201-5447/ (415) 568-9348

         bjones@evcgroup.com; jismail@evcgroup.com



         Media Contact:

         EVC Group, Inc.Chris Gale

         (646) 201-5431

         cgale@evcgroup.com
Source: AngioDynamics

News Provided by Acquire Media